Loading...
XSHG
605388
, Last price  
Name

Juneyao Grand Healthy Drinks Co Ltd

Chart & performance

D1W1MN
XSHG:605388 chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
2.14%
Rev. 5Y
9.35%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.33b
-8.67%
1,101,416,3431,146,000,4291,286,787,3651,245,909,502851,899,377913,598,918986,104,2461,634,102,0301,458,166,4831,331,692,388
Net income
-190m
L+553.26%
174,509,326227,323,745281,427,156295,332,643213,834,515146,987,70976,735,84657,575,883-29,116,349-190,204,593
CFO
22m
-31.91%
82,741,900282,316,331391,638,229353,242,96081,721,356179,878,265-284,388,32985,795,39832,645,60422,229,368
Dividend
Jun 20, 20250.08 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hubei Juneyao Health Drinks Co., Ltd. is dedicated to the full spectrum of activities involved in probiotic beverages, spanning their innovation, manufacturing, commercialization, and distribution. Their product portfolio is extensive, featuring not only drinks enriched with lactic acid bacteria but also various herbal and soothing beverages. These items are marketed under their distinct brand names, such as weiwei, Xiaomengxing, and werdery. This enterprise was established in 1994 and maintains its primary offices in Yichang, China.
IPO date
Aug 18, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT